Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (801-810 of 6,084) with videos related to

Pageof 609
Sort By:
The Prostate|March 21, 2012
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/mlGiuseppe Lucarelli, Margherita Fanelli, Angela Maria Vittoria Larocca, et al.
The Prostate|April 5, 2012
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growthChristian Ruiz, Martin Oeggerli, Markus Germann, et al.
The Prostate|December 14, 2011
MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancerBin Xu, Ning Wang, Xuhui Wang, et al.
The Prostate|December 14, 2011
Association of 5α-reductase inhibitor use and pathological features of prostate cancer in men undergoing radical prostatectomySung Kyu Hong, Jong Jin Oh, Sangchul Lee, et al.
The Prostate|April 20, 2012
Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancerMichael G Heckman, Alexander S Parker, Kevin J Wu, et al.
The Prostate|January 1, 1990
A case-control study of prostatic cancer in Kyoto, Japan: sexual risk factorsK Oishi, K Okada, O Yoshida, et al.
The Prostate|October 21, 2014
Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancerJose D Murga, Sameer M Moorji, Amy Q Han, et al.
The Prostate|October 21, 2014
Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancerJune Escara-Wilke, Jill M Keller, Kathleen M Woods Ignatoski, et al.
The Prostate|November 1, 2014
18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET)Reto Bertolini, Christine Goepfert, Thomas Andrieu, et al.
The Prostate|January 1, 1989
Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humansA Vermeulen, V A Giagulli, P De Schepper, et al.
Pageof 609

Showing results (801-810 of 6,084) with videos related to

Sort By:
Pageof 609
The Prostate|March 21, 2012
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/mlGiuseppe Lucarelli, Margherita Fanelli, Angela Maria Vittoria Larocca, et al.
The Prostate|April 5, 2012
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growthChristian Ruiz, Martin Oeggerli, Markus Germann, et al.
The Prostate|December 14, 2011
MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancerBin Xu, Ning Wang, Xuhui Wang, et al.
The Prostate|December 14, 2011
Association of 5α-reductase inhibitor use and pathological features of prostate cancer in men undergoing radical prostatectomySung Kyu Hong, Jong Jin Oh, Sangchul Lee, et al.
The Prostate|April 20, 2012
Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancerMichael G Heckman, Alexander S Parker, Kevin J Wu, et al.
The Prostate|January 1, 1990
A case-control study of prostatic cancer in Kyoto, Japan: sexual risk factorsK Oishi, K Okada, O Yoshida, et al.
The Prostate|October 21, 2014
Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancerJose D Murga, Sameer M Moorji, Amy Q Han, et al.
The Prostate|October 21, 2014
Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancerJune Escara-Wilke, Jill M Keller, Kathleen M Woods Ignatoski, et al.
The Prostate|November 1, 2014
18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET)Reto Bertolini, Christine Goepfert, Thomas Andrieu, et al.
The Prostate|January 1, 1989
Hormonal effects of an orally active 4-azasteroid inhibitor of 5 alpha-reductase in humansA Vermeulen, V A Giagulli, P De Schepper, et al.
Pageof 609